These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38296900)

  • 21. A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease.
    Boeddrich A; Haenig C; Neuendorf N; Blanc E; Ivanov A; Kirchner M; Schleumann P; Bayraktaroğlu I; Richter M; Molenda CM; Sporbert A; Zenkner M; Schnoegl S; Suenkel C; Schneider LS; Rybak-Wolf A; Kochnowsky B; Byrne LM; Wild EJ; Nielsen JE; Dittmar G; Peters O; Beule D; Wanker EE
    Genome Med; 2023 Jul; 15(1):50. PubMed ID: 37468900
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attenuation of Alzheimer's brain pathology in 5XFAD mice by PTH
    Chen L; Xiong L; Yao L; Pan J; Arzola E; Zhu X; Mei L; Xiong WC
    Alzheimers Res Ther; 2023 Mar; 15(1):53. PubMed ID: 36918976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The absence of myelin basic protein promotes neuroinflammation and reduces amyloid β-protein accumulation in Tg-5xFAD mice.
    Ou-Yang MH; Van Nostrand WE
    J Neuroinflammation; 2013 Nov; 10():134. PubMed ID: 24188129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Oral Iron Chelator, Deferasirox, Reverses the Age-Dependent Alterations in Iron and Amyloid-β Homeostasis in Rat Brain: Implications in the Therapy of Alzheimer's Disease.
    Banerjee P; Sahoo A; Anand S; Bir A; Chakrabarti S
    J Alzheimers Dis; 2016; 49(3):681-93. PubMed ID: 26484920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peptide aptamer targeting Aβ-PrP-Fyn axis reduces Alzheimer's disease pathologies in 5XFAD transgenic mouse model.
    Ali T; Klein AN; Vu A; Arifin MI; Hannaoui S; Gilch S
    Cell Mol Life Sci; 2023 May; 80(6):139. PubMed ID: 37149826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective effects of CCL01 against Aβ-induced neurotoxicity in 5xFAD transgenic mouse model of Alzheimer's disease.
    Ju IG; Son SY; Lee S; Im H; Huh E; Eo H; Choi JG; Sohn MW; Yim SV; Kim SY; Kim DH; Lee CH; Oh MS
    Biomed Pharmacother; 2023 Feb; 158():114105. PubMed ID: 36508997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective disruption of TLR2-MyD88 interaction inhibits inflammation and attenuates Alzheimer's pathology.
    Rangasamy SB; Jana M; Roy A; Corbett GT; Kundu M; Chandra S; Mondal S; Dasarathi S; Mufson EJ; Mishra RK; Luan CH; Bennett DA; Pahan K
    J Clin Invest; 2018 Oct; 128(10):4297-4312. PubMed ID: 29990310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microglial mTOR Activation Upregulates Trem2 and Enhances β-Amyloid Plaque Clearance in the
    Shi Q; Chang C; Saliba A; Bhat MA
    J Neurosci; 2022 Jul; 42(27):5294-5313. PubMed ID: 35672148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer's Disease Mice.
    Jeong YJ; Kang GY; Kwon JH; Choi HD; Pack JK; Kim N; Lee YS; Lee HJ
    Curr Alzheimer Res; 2015; 12(5):481-92. PubMed ID: 26017559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypoxia-inducible factors as neuroprotective agent in Alzheimer's disease.
    Ashok BS; Ajith TA; Sivanesan S
    Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):327-334. PubMed ID: 28004401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid β-induced Mesenteric Inflammation in an Alzheimer's Disease Transgenic Mouse Model.
    Ano Y; Ikado K; Uchida K; Nakayama H
    Curr Alzheimer Res; 2020; 17(1):52-59. PubMed ID: 32048974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scavenger Receptor Class B Type I Deficiency Induces Iron Overload and Ferroptosis in Renal Tubular Epithelial Cells
    Yang L; Liu Q; Lu Q; Xiao JJ; Fu AY; Wang S; Ni L; Hu JW; Yu H; Wu X; Zhang BF
    Antioxid Redox Signal; 2024 Jul; 41(1-3):56-73. PubMed ID: 38062756
    [No Abstract]   [Full Text] [Related]  

  • 33. Brain microvasculature and hypoxia-related proteins in Alzheimer's disease.
    Grammas P; Tripathy D; Sanchez A; Yin X; Luo J
    Int J Clin Exp Pathol; 2011 Aug; 4(6):616-27. PubMed ID: 21904637
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitor of Differentiation-1 and Hypoxia-Inducible Factor-1 Mediate Sonic Hedgehog Induction by Amyloid Beta-Peptide in Rat Cortical Neurons.
    Hung YH; Chang SH; Huang CT; Yin JH; Hwang CS; Yang LY; Yang DI
    Mol Neurobiol; 2016 Mar; 53(2):793-809. PubMed ID: 25502463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation.
    Eimer WA; Vassar R
    Mol Neurodegener; 2013 Jan; 8():2. PubMed ID: 23316765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neuroprotective N-terminal amyloid-β core hexapeptide reverses reactive gliosis and gliotoxicity in Alzheimer's disease pathology models.
    Lantz MJ; Roberts AM; Delgado DD; Nichols RA
    J Neuroinflammation; 2023 May; 20(1):129. PubMed ID: 37245024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation.
    Malm T; Mariani M; Donovan LJ; Neilson L; Landreth GE
    J Neuroinflammation; 2015 Jan; 12():7. PubMed ID: 25592770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of cytosolic cathepsin D in Alzheimer's disease pathology: Protective cellular effects of PLGA nanoparticles against β-amyloid-toxicity.
    Wang Y; Wu Q; Anand BG; Karthivashan G; Phukan G; Yang J; Thinakaran G; Westaway D; Kar S
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):686-706. PubMed ID: 32716575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody.
    Faresjö R; Sehlin D; Syvänen S
    Fluids Barriers CNS; 2023 May; 20(1):34. PubMed ID: 37170266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Breakdown in Metabolic Reprogramming Causes Microglia Dysfunction in Alzheimer's Disease.
    Baik SH; Kang S; Lee W; Choi H; Chung S; Kim JI; Mook-Jung I
    Cell Metab; 2019 Sep; 30(3):493-507.e6. PubMed ID: 31257151
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.